Bacteria engineered to sense and reduce glucose levels could be the future of type 2 diabetes treatments, following pre-clinical trials on animal models. Continue Reading Category: Diabetes , Illnesses and conditions , Body and Mind , Refractor: Science & Health Tags: Type 2 diabetes , GLP-1 receptor agonists , Weight Loss , Probiotic , Diet